CMG901

· Keymed Biosciences Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CMG901, covering 2025-02-12 to 2025-02-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901 [Phase 1]